Approved accessible "alogliptin tablets"

Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Alogliptin is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class.  Note: (see Drugs@FDA for complete indication)

What is NESINA?  • NESINA is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. • NESINA is unlikely by itself to cause your blood sugar to be lowered to a dangerous level (hypoglycemia). However, hypoglycemia may still occur with NESINA. • NESINA is not for people with type 1 diabetes. • NESINA is not for people with diabetic ketoacidosis (increased ketones in blood or urine). It is not known if NESINA is safe and effective in children under the age of 18. Active ingredient: alogliptin Inactive ingredients: mannitol, microcrystalline cellulose, hydroxypropyl cellulose, croscarmellose sodium and magnesium stearate. In addition, the film-coating contains the following inactive ingredients: hypromellose, titanium dioxide, ferric oxide (red or yellow) and polyethylene glycol and is marked with gray F1 printing ink.

How To access alogliptin tablets?

NESINA (alogliptin tablets) for oral use Initial U.S. Approval: 2013
To access alogliptin tablets sold under the brand name can be made available on request to patient if the drug has not been approved or is not available in your country. For information or advice, call IPN's Pharmaceutical Expert. Our expert will be happy to take your query and guide with an effective solution. Be free and call today for full support at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj)